Off-label prescription of tigecycline: Clinical and microbiological characteristics and outcomes

International Journal of Antimicrobial Agents

Volumn 36, Issue 5, 2010, Pages 471-472

  Conde Estévez, David ^a   Grau, Santiago ^a   Horcajada, Juan Pablo ^a   Luque, Sonia ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COLISTIN; TIGECYCLINE;

ABDOMINAL INFECTION; ADULT; BACTERIUM CULTURE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTIOUS PNEUMONIA; INTENSIVE CARE UNIT; LENGTH OF STAY; LETTER; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOFT TISSUE INFECTION; STENOTROPHOMONAS MALTOPHILIA; SURGICAL WARD; TREATMENT DURATION; TREATMENT INDICATION; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MINOCYCLINE; PRESCRIPTIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77957689063     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.07.006     Document Type: Letter

References (6)

1. Pankey G.A. Tigecycline. J Antimicrob Chemother 2005, 56:470-480.
2. Ellis-Grosse E.J., Babinchak T., Dartois N., Rose G., Loh E. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam. Clin Infect Dis 2005, 41(Suppl 5):S341-S353. Tigecycline 300 cSSSI Study Group; Tigecycline 305 cSSSI Study Group.
3. Oliva M.E., Rekha A., Yellin A., Pasternak J., Campos M., Rose G.M., et al. A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov identifier: NCT00081744]. BMC Infect Dis 2005, 5:88.
4. Curcio D., Fernández F., Cané A., Barcelona L., Stamboulian D. Indications of a new antibiotic in clinical practice: results of the tigecycline initial use registry. Braz J Infect Dis 2008, 12:198-201.
5. Curcio D. Off-label use of antibiotics in hospitalized patients: focus on tigecycline. J Antimicrob Chemother 2009, 64:1344-1346.
6. Le Gall J.R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. [Erratum in: JAMA 1994;271:1321].